Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Intra-Cellular Therapies, Inc.ITCI · Entity 81206 | Director | September 30, 2021 | October 04, 2021 |
| OPKO HEALTH, INC.OPK · Entity 4891 | Director | June 24, 2021 | June 25, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Intra-Cellular Therapies, Inc.
Report date September 30, 2021 · Filed October 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectHeld by the Lerner Family Trust UAD 11/14/94 | 96,663 |
Reported balance
After 2021-09-30 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-09-30 · Grant · Acquired 402 · Balance 96,663 F1: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Direct | 11,430 |
Reported balance
Holding disclosure · report date 2021-09-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 11,430 |
Filing footnotes · ownership attribution and instrument terms
F1: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein.
OPKO HEALTH, INC.
Report date June 24, 2021 · Filed June 25, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.77 · Expires 2031-06-23 | Direct | 30,000 |
Reported balance
After 2021-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-24 · Grant · Acquired 30,000 · Balance 30,000 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SEQUENOM INC
Report date September 07, 2016 · Filed September 07, 2016
Section 16 reporting ended · disclosed 2016-09-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-09-07 transaction · row 1
1 source rowRow 1 · 2016-09-07 · Other · Disposed 27,383 · Balance 0 F1: Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated July 26, 2016, among the Issuer, Laboratory Corporation of America Holdings, a Delaware corporation ("Parent"), and Savoy Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") in exchange for a cash consideration of $2.40 per share, without interest, subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Merger"). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.11 · Expires 2026-06-14 | Direct | 0 |
Reported balance
After 2016-09-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-09-07 · Disposition to issuer · Disposed 20,000 · Balance 0 F2: This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.60 · Expires 2026-01-03 | Direct | 0 |
Reported balance
After 2016-09-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-09-07 · Disposition to issuer · Disposed 34,286 · Balance 0 F2: This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated July 26, 2016, among the Issuer, Laboratory Corporation of America Holdings, a Delaware corporation ("Parent"), and Savoy Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") in exchange for a cash consideration of $2.40 per share, without interest, subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Merger").
F2: This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2017 Filed Mar 15, 2017 22:30 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GiftCommon Stock | 44,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020903 · doc4.xml · nonDerivative · entry 3 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 22:30 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | Tax withholdingCommon Stock | 5,177 | $7.92 | $41,001.84 |
DisclosureSEC source: 0001209191-17-020903 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,823 F1 · shares: Represents number of shares withheld by the Company at the direction of the reporting person for the payment of exercise price. No shares of Common Stock were sold by the reporting person in connection with this transaction. The reporting person has retained the net number of shares issued upon the exercise of the option (14,823 shares). F2 · price: Closing market price of the Company's common stock on the transaction date. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 22:30 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | Exercise / conversionCommon Stock | 20,000 | $2.05 | $41,000.00 |
DisclosureSEC source: 0001209191-17-020903 · doc4.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 16:23 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 911 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000224 · doc4.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,797 Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 16:43 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-144330 · doc4.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,886 Read SEC document |
| September 07, 2016 Filed Sep 7, 2016 17:08 UTC | SEQUENOM INC SQNM · Entity 182543 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 34,286 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001209191-16-140434 · doc4.xml · derivative · entry 3 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,286 shares Expires 2026-01-03 F2 · price: This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger. F2 · derivative.exercise_date: This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger. Read SEC document |
| September 07, 2016 Filed Sep 7, 2016 17:08 UTC | SEQUENOM INC SQNM · Entity 182543 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | Not disclosed Strike: $1.11 | Not disclosed |
DisclosureSEC source: 0001209191-16-140434 · doc4.xml · derivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2026-06-14 F2 · price: This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger. F2 · derivative.exercise_date: This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger. Read SEC document |
| September 07, 2016 Filed Sep 7, 2016 17:08 UTC | SEQUENOM INC SQNM · Entity 182543 | OtherCommon Stock | 27,383 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-140434 · doc4.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated July 26, 2016, among the Issuer, Laboratory Corporation of America Holdings, a Delaware corporation ("Parent"), and Savoy Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") in exchange for a cash consideration of $2.40 per share, without interest, subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Merger"). Read SEC document |
| April 15, 2014 Filed Mar 15, 2017 22:30 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GiftCommon Stock | 31,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020902 · doc5.xml · nonDerivative · entry 4 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 105,749 Read SEC document |
| April 15, 2014 Filed Mar 15, 2017 22:30 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GiftCommon Stock | 31,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020902 · doc5.xml · nonDerivative · entry 3 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| January 16, 2014 Filed Mar 15, 2017 22:30 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GiftCommon Stock | 19,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020902 · doc5.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 73,877 F1 · ownership.nature: Securites held by the Lerner Family Trust, Richard A & Nicola G Lerner Trustees U/A Dated 11/14/1994. Read SEC document |
| January 16, 2014 Filed Mar 15, 2017 22:30 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GiftCommon Stock | 19,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020902 · doc5.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| May 16, 2012 Filed Mar 15, 2017 22:29 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GiftCommon Stock | 54,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020901 · doc5.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 54,400 F1 · ownership.nature: Securites held by the Lerner Family Trust, Richard A & Nicola G Lerner Trustees U/A Dated 11/14/1994. Read SEC document |
| May 16, 2012 Filed Mar 15, 2017 22:29 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GiftCommon Stock | 54,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020901 · doc5.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.